ZA903181B - Pharmaceutical formulation - Google Patents

Pharmaceutical formulation

Info

Publication number
ZA903181B
ZA903181B ZA903181A ZA903181A ZA903181B ZA 903181 B ZA903181 B ZA 903181B ZA 903181 A ZA903181 A ZA 903181A ZA 903181 A ZA903181 A ZA 903181A ZA 903181 B ZA903181 B ZA 903181B
Authority
ZA
South Africa
Prior art keywords
medicament
pharmaceutical formulation
chewable
tablet
chewability
Prior art date
Application number
ZA903181A
Other languages
English (en)
Inventor
Ian James Bolt
James Bolt Ian
David Roy Merrifield
Roy Merrifield David
Paul Laurence Carter
Laurence Carter Paul
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of ZA903181B publication Critical patent/ZA903181B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
ZA903181A 1989-04-28 1990-04-26 Pharmaceutical formulation ZA903181B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898909793A GB8909793D0 (en) 1989-04-28 1989-04-28 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
ZA903181B true ZA903181B (en) 1991-06-26

Family

ID=10655920

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA903181A ZA903181B (en) 1989-04-28 1990-04-26 Pharmaceutical formulation

Country Status (17)

Country Link
US (2) US5225197A (xx)
EP (1) EP0396335B1 (xx)
JP (1) JP2992761B2 (xx)
KR (1) KR0167554B1 (xx)
AT (1) ATE101034T1 (xx)
AU (1) AU627298B2 (xx)
CA (1) CA2015536C (xx)
CY (1) CY1957A (xx)
DE (1) DE69006385T2 (xx)
DK (1) DK0396335T3 (xx)
ES (1) ES2062353T3 (xx)
GB (1) GB8909793D0 (xx)
HK (1) HK1004522A1 (xx)
IE (1) IE63806B1 (xx)
NZ (1) NZ233441A (xx)
PT (1) PT93877B (xx)
ZA (1) ZA903181B (xx)

Families Citing this family (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2633181B1 (fr) * 1988-06-24 1992-01-10 Glaxo Lab Sa Composition pharmaceutique a base de ranitidine et son procede de preparation
ES2097155T3 (es) * 1989-10-02 1997-04-01 Cima Labs Inc Forma de dosificacion efervescente y metodo de administracion.
US5223264A (en) * 1989-10-02 1993-06-29 Cima Labs, Inc. Pediatric effervescent dosage form
US5178878A (en) * 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
US5064656A (en) * 1989-11-14 1991-11-12 Dr. Gergely & Co. Uncoated pharmaceutical reaction tablet
US5744500A (en) * 1990-01-03 1998-04-28 Teva Pharmaceutical Industries, Ltd. Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
US5814337A (en) * 1992-10-07 1998-09-29 Beecham Group Plc Pharmaceutical formulation
GB9009473D0 (en) 1990-04-27 1990-06-20 Beecham Group Plc Pharmaceutical formulation
US5670170A (en) * 1990-04-27 1997-09-23 Beecham Group P.L.C. Pharamaceutical formulation
GB9027827D0 (en) * 1990-12-21 1991-02-13 Glaxo Laboratoires Pharmaceutical compositions
US5468504A (en) * 1990-12-21 1995-11-21 Laboratoires Glaxo S.A. Effervescent pharmaceutical compositions
CZ225893A3 (en) * 1991-04-04 1994-04-13 Procter & Gamble Chewing antacid preparation
GB9108128D0 (en) * 1991-04-15 1991-06-05 Zambeletti Spa L Novel formulation
EP0574624B1 (en) * 1992-06-17 1997-09-10 Laboratoires Glaxo Sa Pharmaceutical compositions
US5330760A (en) * 1992-08-27 1994-07-19 Sterling Winthrop Inc. Effervescent antacid
ZA939117B (en) * 1992-12-04 1994-08-05 Susanna Elizabeth Chalmers Pharmaceutical product
HU217125B (hu) * 1993-03-10 1999-11-29 Béres Rt. Cukor- és nátriummentes pezsgőtabletta és -granulátum és eljárás azok előállítására
WO1995005165A1 (en) * 1993-08-13 1995-02-23 Bayer Corporation Hydrolyzed gelatin as a flavor enhancer in a chewable tablet
US5622980A (en) * 1993-08-17 1997-04-22 Applied Analytical Industries, Inc. Oral compositions of H2-antagonists
FR2709420B1 (fr) * 1993-09-01 1995-11-17 Sogeval Comprimé vétérinaire plus spécialement destiné aux chats.
FI103442B1 (fi) * 1993-09-24 1999-06-30 Nokia Telecommunications Oy Digitaalinen radiolinkkijärjestelmä ja radiolinkkilaite
IL112779A (en) * 1994-03-01 1999-11-30 Gergely Gerhard Granular product or tablet containing an efferescent system and an active pharmaceutical substance and its preparation
US5399356A (en) * 1994-03-24 1995-03-21 The Procter & Gamble Company Process for making solid dose forms containing bismuth
US5637313A (en) * 1994-12-16 1997-06-10 Watson Laboratories, Inc. Chewable dosage forms
US5639475A (en) * 1995-02-03 1997-06-17 Eurand America, Incorporated Effervescent microcapsules
FR2732217B1 (fr) * 1995-03-29 1997-06-06 Hesnard Xavier Forme d'administration solide a usage oral
AU2814995A (en) * 1995-05-26 1996-12-11 Angelo A. Caputo Chewing gum with fluoride and citric acid
US20030109503A1 (en) * 1995-06-06 2003-06-12 Smithkline Beecham P.L.C. Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
TW442287B (en) * 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
PE10898A1 (es) * 1995-06-13 1998-03-20 American Home Prod Formulaciones orales de etodolac s (+)-
WO1997009042A1 (en) * 1995-09-07 1997-03-13 Smithkline Beecham Corporation Pharmaceutical formulation
IL115357A (en) * 1995-09-20 2000-01-31 Teva Pharma Stable compositions containing N-propargyl-1-aminoindan and polyhydric alcohols
US5807577A (en) * 1995-11-22 1998-09-15 Lab Pharmaceutical Research International Inc. Fast-melt tablet and method of making same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
TWI225402B (en) 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
AT407701B (de) * 1996-08-12 2001-05-25 Biochemie Gmbh Zur direkttablettierung geeignete mischung, die als wesentliche komponenten amoxicillin-trihydrat und das kaliumsalz der clavulansäure enthält und verfahren zur herstellung dieser mischung
PT893992E (pt) * 1996-04-16 2004-06-30 Novartis Consumer Health Sa Formas de dosagem oral de desintegracao rapida
GB9613470D0 (en) 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
FR2753097A1 (fr) * 1996-09-11 1998-03-13 Barrau Francois Gel aqueux ou hydroalcoolique extemporane a viscosite controlee
US6649186B1 (en) 1996-09-20 2003-11-18 Ethypharm Effervescent granules and methods for their preparation
US6488961B1 (en) 1996-09-20 2002-12-03 Ethypharm, Inc. Effervescent granules and methods for their preparation
US5837286A (en) * 1997-01-15 1998-11-17 Pandya; Harish B. Taste masking for unplatable formulations
US20030124187A1 (en) * 1997-02-14 2003-07-03 Smithkline Beecham Laboratoires Pharmaceutiques, Pharmaceutical formulations comprising amoxycillin and clavulanate
US6024981A (en) 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
US6667056B2 (en) 1997-07-23 2003-12-23 Chiesi Farmaceutici S.P.A. Pharmaceutical compositions containing an effervescent acid-base couple
US6673380B2 (en) 1998-11-17 2004-01-06 Mcneil-Ppc, Inc. Fortified confectionery delivery systems and methods of preparation thereof
WO1999043306A1 (en) * 1998-02-26 1999-09-02 Banyu Pharmaceutical Co., Ltd. An orally disintegrating composition and its manufacturing method
US20030091629A1 (en) 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
US6974590B2 (en) 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
DE19814257A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Brauseformulierungen
JP4827296B2 (ja) * 1998-06-11 2011-11-30 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー デラビルジン錠製剤
US6365182B1 (en) 1998-08-12 2002-04-02 Cima Labs Inc. Organoleptically pleasant in-mouth rapidly disintegrable potassium chloride tablet
US6296868B1 (en) 1998-11-19 2001-10-02 Advanced Technology Pharmaceuticals Corporation Chewable tablets containing mannitol and aspartame
FR2786395A1 (fr) * 1998-12-01 2000-06-02 Virbac Sa Compositions seches solubles en presence d'eau et evitant la reaction de maillard a l'etat sec, leur preparation et leurs applications
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US20020006433A1 (en) * 1999-04-29 2002-01-17 Nigel P. Davidson Pharmaceutical formulations
US6589555B2 (en) 1999-12-29 2003-07-08 Mahendra Pandya Effervescent vitaceutical compositions and related methods
ATE329583T1 (de) * 2000-08-18 2006-07-15 Pharmacia Corp Schnell zerfallende orale arzneizubereitung enthaltend valdecoxib
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
EP1330236A2 (en) 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
JP2004514732A (ja) * 2000-12-06 2004-05-20 ファルマシア・コーポレーション 迅速に分散する医薬組成物
MXPA04007169A (es) * 2002-01-25 2004-10-29 Santarus Inc Suministro transmucosal de inhibidores de bomba de protones.
ES2302926T5 (es) 2002-04-25 2012-08-23 Banner Pharmacaps, Inc. Cápsula blanda masticable
US7189416B2 (en) * 2002-11-23 2007-03-13 Glykon Technologies Group, Llc Method for stable and controlled delivery of (-)-hydroxycitric acid
US20040223921A1 (en) * 2003-05-07 2004-11-11 Rau Allen H. Oral care tablet
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20050089502A1 (en) * 2003-08-21 2005-04-28 Todd Schansberg Effervescent delivery system
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
US7282217B1 (en) 2003-08-29 2007-10-16 Kv Pharmaceutical Company Rapidly disintegrable tablets
WO2005051350A2 (en) * 2003-10-28 2005-06-09 Torrent Pharmaceuticals Limited Water dispersible tablet
US20070048375A1 (en) * 2003-12-19 2007-03-01 Wolfgang Wiehl Effervescent preparation of a basic medicinally active substance
WO2005065319A2 (en) 2003-12-31 2005-07-21 Cima Labs Inc. Generally linear effervescent oral fentanyl dosage form and methods of administering
AU2004311879B2 (en) 2003-12-31 2010-08-05 Cima Labs Inc. Effervescent oral opiate dosage form
US7858121B2 (en) 2003-12-31 2010-12-28 Cima Labs, Inc. Effervescent oral fentanyl dosage form and methods of administering fentanyl
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8216610B2 (en) 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
JP2008500288A (ja) * 2004-05-28 2008-01-10 イメイジノット ピーティーワイ エルティーディー 経口治療用化合物の供給系
KR100676617B1 (ko) * 2004-06-18 2007-01-30 주식회사유한양행 아목시실린 및/또는 클라불란산 또는 이의 염을 함유하는경구용 현탁정제 조성물
AU2006317530B2 (en) * 2005-11-28 2011-09-01 Imaginot Pty Ltd Oral therapeutic compound delivery system
US7611739B2 (en) * 2006-01-06 2009-11-03 Amerilab Technologies, Inc. Method of using guava extract and composition including guava extract
US20090004270A1 (en) * 2006-01-06 2009-01-01 Amerilab Technologies, Inc. Method of using guava extract
US20070298078A1 (en) * 2006-06-27 2007-12-27 Harrison Michael D Water Soluble Article for Imparting Dietary Fiber to Bottled Water
RS55118B1 (sr) 2010-02-17 2016-12-30 Veloxis Pharmaceuticals As Stabilizovana takrolimus kompozicija
EP2649989B1 (en) 2012-04-13 2017-10-18 King Saud University Method for preparing a solid dispersion, solid dispersion obtained thereby and use thereof
US20140371174A1 (en) 2013-06-12 2014-12-18 The Procter & Gamble Company Effervescent Dosage Form
CN104363897A (zh) 2012-06-12 2015-02-18 宝洁公司 泡腾剂型
JP6253393B2 (ja) * 2013-12-19 2017-12-27 花王株式会社 固形状組成物
WO2020070236A1 (en) 2018-10-04 2020-04-09 Adeptio Pharmaceuticals Limited (+)-alpha-dihydrotetrabenazine dosage regimen for treating movement disorders

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1098116A (fr) * 1954-01-07 1955-07-18 Marocaine De Prod Chim Et Agri Procédé de fabrication de glossettes contenant des compositions destinées à l'absorption intratissulaire
US3039922A (en) * 1959-08-17 1962-06-19 Carter Prod Inc Method of administering tablets having decongestant and anti-histaminic activity
FR2294M (fr) * 1962-07-30 1964-01-27 Dausse Lab Composition a base de sorbitol.
GB1113492A (en) * 1964-05-20 1968-05-15 Bristol Myers Co Chewable tablets comprising a penicillin antibiotic
SE369036B (xx) * 1972-06-30 1974-08-05 Astra Laekemedel Ab
US4127645A (en) * 1976-05-21 1978-11-28 Life Savers, Inc. Effervescent tablet and method
US4639368A (en) * 1984-08-23 1987-01-27 Farmacon Research Corporation Chewing gum containing a medicament and taste maskers
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US4704269A (en) * 1985-06-11 1987-11-03 Hudson Pharmaceutical Corporation Effervescent antacid and analgesic compositions
WO1987001936A1 (en) * 1985-09-25 1987-04-09 Gerhard Gergely Desintegration tablet and process for its manufacture
GB8528195D0 (en) * 1985-11-15 1985-12-18 Boots Co Plc Therapeutic compositions
US4851226A (en) * 1987-11-16 1989-07-25 Mcneil Consumer Products Company Chewable medicament tablet containing means for taste masking
US5178878A (en) * 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles

Also Published As

Publication number Publication date
ES2062353T3 (es) 1994-12-16
PT93877A (pt) 1990-11-20
DE69006385T2 (de) 1994-05-19
EP0396335B1 (en) 1994-02-02
JPH02295919A (ja) 1990-12-06
KR0167554B1 (ko) 1999-01-15
JP2992761B2 (ja) 1999-12-20
HK1004522A1 (en) 1998-11-27
DE69006385D1 (de) 1994-03-17
US5225197A (en) 1993-07-06
DK0396335T3 (da) 1994-03-07
AU627298B2 (en) 1992-08-20
PT93877B (pt) 1996-09-30
IE63806B1 (en) 1995-06-14
EP0396335A1 (en) 1990-11-07
IE901489L (en) 1990-10-28
GB8909793D0 (en) 1989-06-14
CA2015536C (en) 1999-08-24
AU5391490A (en) 1990-11-01
NZ233441A (en) 1992-03-26
CY1957A (en) 1990-04-26
CA2015536A1 (en) 1990-10-28
US5962022A (en) 1999-10-05
KR900015716A (ko) 1990-11-10
ATE101034T1 (de) 1994-02-15

Similar Documents

Publication Publication Date Title
CY1957A (en) Pharmaceutical formulation
CA2061917A1 (en) Pediatric effervescent dosage form
PT841903E (pt) Composicao farmaceutica oral contendo agentes activos antimicrobianos e pantoprazole com libertacao diferida
DE69739967D1 (de) Eine im Mund schnell zerfallende Tablette
IT1208735B (it) Formulazioni farmaceutiche a basedi arecolina e simili,lore preparazione ed impiego nel trattamento di disturbi della memoria
NO912001L (no) Buccal tablett med hurtig utlevering.
AU7378987A (en) Drug delivery device, its preparation and use
CA2102630A1 (en) Pharmaceutical compositions of compacted medicaments
IE882960L (en) Osmotic dosage form for administering isradipine
IL96995A0 (en) Pharmaceutical compositions containing pimobendan and their preparation
IL159217A0 (en) An oral pharmaceutical formulation comprising a basic pharmaceutically active ingredient having ph-dependent solubility, a process for the manufacture thereof and use thereof in medicine
DE68903988D1 (de) Acetylcystein enthaltende mundloesliche arzneimittel.
IL103213A (en) Medicaments for treating gastrointestinal disorders containing ranitidine bismuth citrate together with certain helicobacter pylori-inhibiting antibiotics
DE3774415D1 (de) Pharmazeutische zusammensetzung fuer die prophylaxe und die therapie des magengeschwuers.
PH24860A (en) Pharmaceutical compositions containing dyclonine hc1 and phenol
HUT47233A (en) Process for producing pharmaceutical comprising phenol derivatives as active ingredient and for producing the active ingredients
ZA945431B (en) Use of benzydamine in the treatment of pathological conditions caused by TNF
AU7111587A (en) Perhydrothiazepine and perhydroazepine derivatives,their preparation and their therapeutic use
GB2251620B (en) (S)-11-Hydroxy-10-methylaporphine, its physiologically acceptable salts and pharmaceutical compositions thereof
FR2790201B1 (fr) Preparations therapeutiques a base d'alcool ethylique et de vitamines
CA2161683A1 (en) Veterinary composition containing a proton pump inhibitor
ITRM910945A0 (it) Procedimento e composizione per ottenere una medicina contro il male secco.
IT8822160V0 (it) Struttura di letto provvista di una testata in profilati orizzontali predisposti per l'alloggiamento di parti imbottite variamente dimensionate e facilmente intercambiabili.